Mariner LLC Purchases 250,219 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Mariner LLC lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 103.7% during the 4th quarter, HoldingsChannel reports. The firm owned 491,550 shares of the medical instruments supplier’s stock after acquiring an additional 250,219 shares during the period. Mariner LLC’s holdings in DENTSPLY SIRONA were worth $9,330,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Nordea Investment Management AB boosted its holdings in shares of DENTSPLY SIRONA by 245.0% during the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock valued at $4,754,000 after buying an additional 178,639 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after purchasing an additional 1,244,326 shares during the period. Bank of New York Mellon Corp increased its stake in shares of DENTSPLY SIRONA by 27.9% during the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock valued at $45,611,000 after purchasing an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of DENTSPLY SIRONA by 1.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier’s stock valued at $39,880,000 after purchasing an additional 35,360 shares during the last quarter. Finally, Barclays PLC boosted its position in shares of DENTSPLY SIRONA by 21.8% in the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock worth $8,301,000 after purchasing an additional 54,920 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction dated Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.52% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts recently weighed in on XRAY shares. Mizuho reduced their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, March 13th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating and reduced their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Barrington Research dropped their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a research report on Friday, February 28th. Finally, StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Thirteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, DENTSPLY SIRONA has an average rating of “Hold” and a consensus price target of $22.58.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $12.83 on Friday. The firm has a 50 day moving average of $15.72 and a 200 day moving average of $18.82. The firm has a market capitalization of $2.56 billion, a price-to-earnings ratio of -6.20, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $31.00. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were given a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.99%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.07%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.